Dr. Meghraj Ingle reminds nonalcoholic fatty liver disease (NAFLD), which got no noticeable symptoms in its early stages, can ...

A modeling study predicts a substantial rise in MASLD prevalence and associated liver-related complications in the United ...

Alcoholic and non-alcoholic fatty liver disease (NAFLD) are well-known risk factors for colorectal cancer (CRC). NAFLD has emerged as a heterogenous ...

In patients with metabolic dysfunction-associated steatotic liver disease, there is increased risk for heart failure with preserved ejection fraction.

A new study published in the journal of Diabetes Research and Clinical Practice showed that metabolic dysfunction may be ...

The global rise in obesity and type 2 diabetes is fueling an epidemic of MASLD and MASH, now recognized as the leading cause ...

With the rising epidemic of obesity, metabolic syndrome, and type 2 diabetes mellitus in China, metabolic ...

Discover why, to improve screening efficiency, it is crucial to identify patients with elevated hepatocellular carcinoma risk ...

Health department starting fatty liver clinics in district hospitals for early diagnosis and treatment of liver diseases.

Young adulthood obesity is associated with greater odds for MASLD, at-risk MASH, and increased liver stiffness measurement.

Discover how semaglutide aids weight loss in individuals with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD ...

Researchers from Georgia Southern University's Jiann-Ping Hsu College of Public Health have discovered a positive trend in ...